The Mainz-based biopharmaceutical company BioNTech is halting COVID-19 vaccine production in Germany, closing almost all its ...

The German company that pioneered one of the first mRNA coronavirus vaccines is halting production, handing the reins to ...

BioNTech, once celebrated for its COVID-19 vaccines, is grappling with falling demand, restructuring and the departure of its ...

BioNTech is planning site closures affecting up to 1,860 jobs and will buy back $1 billion in shares after announcing the ...

Last year, the High Court ruled that one of Moderna’s patents relating to the messenger RNA (mRNA) technology, which underpinned its COVID-19 vaccine, was valid and that Pfizer and BioNTech’s ...

Data indicate that the LP.8.1-adapted COVID-19 vaccine confers improved immune response against currently dominant and emerging sublineages – including the XFG and NB.1.8.1 variants1 – compared to ...

Phase 3 clinical trial cohort of adults 65+ and 18-64 with at least one underlying risk condition shows at least a 4-fold increase in LP.8.1-neutralizing antibody titers after receiving the ...

As of May 7, an outbreak of hantavirus on a Dutch-flagged cruise ship has killed three people. South Africa’s health ministry ...

The CHMP’s recommendation will be reviewed by the European Commission (EC), which is expected to make its final decision soon. Pfizer and BioNTech have already initiated manufacturing of the ...